Report cover image

Human Vaccines Market to 2027

Publisher QualiKet Research
Published Feb 02, 2022
Length 191 Pages
SKU # QUA17148816

Description

Human Vaccines Market to 2027

Global Human Vaccines Market to 2027

Global Human Vaccines Market Introduction

Vaccines are the biological products which improves immunity against specific disorder or disease. Vaccines are manufactured from living attenuated organisms, or killed disease-causing microorganism. Vaccination plays an important role to maintain sustainable health of people across various countries. Increase in demand vaccination to treat various diseases is expected to fuel the growth of human vaccines market, in this forecast period.

Global Human Vaccines Market Drivers

Increase in prevalence of infectious diseases will increase the demand for vaccines. It is expected to boost the human vaccines market growth. Furthermore, technological advancements in vaccine delivery devices and rise in immunization programs supplement market is expected to propel the growth of global human vaccines market growth. In other hand, rise in government initiatives to create awareness regarding vaccination have the positive impact on global human vaccines market growth.

Global Human Vaccines Market Restraints

However, storage condition of vaccine is the major restraining factor which expected to hinder the growth of global human vaccines market growth. Also, longer timelines required to vaccine production, and high monetary inputs associated with vaccines will affect the global human vaccines market growth.

Global Human Vaccines Market Segmentation

Global Human Vaccines Market is segmented into technology Conjugate Vaccine, Inactivated & Subunit Vaccines, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine, by Patient Type Pediatric Patients, and Adult Patient, by infection type Pneumococcal Infection, DTP, Influenza, Polio, Rotavirus, and Others. Further, Global Human Vaccines Market is segmented into Route of Administration such as Intramuscular & Subcutaneous, Oral, and Others.

Also, Global Human Vaccines Market is segmented into five regions such as North SAmerica, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Global Human Vaccines Market Key Players

Various key players are discussed in this report such as GlaxoSmithKline PLC, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA,Johnson& Johnson, AstraZeneca, Serum Institute of India Pvt. Ltd., , Daiichi Sankyo Company Limited, Bavarian Nordic, Biological , CSL Limited, and Bharat Biotech.

Global Human Vaccines Market Taxonomy

By Technology
  • Conjugate Vaccine
  • Inactivated & Subunit Vaccines
  • Live Attenuated Vaccine
  • Recombinant Vaccine
  • Toxoid Vaccine
By Patient Type
  • Pediatric Patients
  • Adult Patient
By Infection Type
  • Pneumococcal Infection
  • DTP
  • Influenza
  • Polio
  • Rotavirus
  • Others
By Route of Administration
  • Intramuscular & Subcutaneous
  • Oral
  • Others
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

191 Pages
1. Executive Summary
1.1. Market Taxonomy
2. Global Human Vaccines Market Demand (in Value or Size in US$ Mn) Analysis and
Forecast
3. Market Background
3.1. Forecast Factor
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Trends
4. Global Human Vaccines Market Snapshot
5. Global Human Vaccines Market Analysis, By Technology
5.1. Y-o-Y Growth Comparison, By Technology
5.2. Global Human Vaccines Market Share Analysis, By Technology
5.3. Global Human Vaccines Market Size and Forecast, By Technology
5.3.1 Conjugate Vaccine
5.3.2 Inactivated & Subunit Vaccines
5.3.3 Live Attenuated Vaccine
5.3.4 Recombinant Vaccine
5.3.5 Toxoid Vaccine
6. Global Human Vaccines Market Analysis, By Patient Type
6.1. Y-o-Y Growth Comparison, By Patient Type
6.2. Global Human Vaccines Market Share Analysis, By Patient Type
6.3. Global Human Vaccines Market Size and Forecast, By Patient Type
6.3.1 Pediatric Patient
6.3.2 Adult Patient
7. Global Human Vaccines Market Analysis, By Infection Type
7.1. Y-o-Y Growth Comparison, By Infection Type
7.2. Global Human Vaccines Market Share Analysis, By Infection Type
7.3. Global Human Vaccines Market Size and Forecast, By Infection Type
7.3.1 Pneumococcal Infection
7.3.2 DTP
7.3.3 Influenza
7.3.4 Polio
7.3.5 Rotavirus
7.3.6 Others
8. Global Human Vaccines Market Analysis, By Route of Administration
8.1. Y-o-Y Growth Comparison, By Route of Administration
8.2. Global Human Vaccines Market Share Analysis, By Route of Administration
8.3. Global Human Vaccines Market Size and Forecast, By Route of Administration
8.3.1 Intramuscular & Subcutaneous
8.3.2 Oral
8.3.3 Others
9. Global Human Vaccines Market Analysis, By Region
9.1. Y-o-Y Growth Comparison, By Region
9.2. Global Human Vaccines Market Share Analysis, By Region
10. North America Human Vaccines Market Analysis and Forecast (2017-2027)
10.1 Introduction
10.2 North America Human Vaccines Market Analysis, By Technology
10.3 North America Human Vaccines Market Analysis, By Patient Type
10.4 North America Human Vaccines Market Analysis, By Infection Type
10.5 North America Human Vaccines Market Analysis, By Route of Administration
10.6 North America Human Vaccines Market Analysis, By Country
10.6.1 USA
10.6.2 Canada
10.6.3 Mexico
11. Europe Human Vaccines Market Analysis and Forecast (2017-2027)
11.1 Introduction
11.2 Europe Human Vaccines Market Analysis, By Technology
11.3 Europe Human Vaccines Market Analysis, By Patient Type
11.4 Europe Human Vaccines Market Analysis, By Infection Type
11.5 Europe Human Vaccines Market Analysis, Route of Administration
11.6 Europe Human Vaccines Market Analysis, By Country
11.6 .1 Germany
11.6 .2 France
11.6 .3 UK
11.6.4 Rest of Europe
12. Asia Pacific Human Vaccines Market Analysis and Forecast (2017-2027)
12.1 Introduction
12.2 Asia Pacific Human Vaccines Market Analysis, By Technology
12.3 Asia Pacific Human Vaccines Market Analysis, By Patient Type
12.3 Asia Pacific Human Vaccines Market Analysis, By Infection Type
12.4 Asia Pacific Human Vaccines Market Analysis, By Route of Administration
12.5 Asia Pacific Human Vaccines Market Analysis, By Country
12.5.1 China
12.5.2 India
12.5.3 Japan
12.5.4 Rest of Asia Pacific
13. Latin America Human Vaccines Market Analysis and Forecast (2017-2027)
13.1 Introduction
13.2 Latin America Human Vaccines Market Analysis, By Technology
13.3 Latin America Human Vaccines Market Analysis, By Patient Type
13.4 Latin America Human Vaccines Market Analysis, By Infection Type
13.5 Latin America Human Vaccines Market Analysis, By Route of Administration
14. Middle East & Africa Human Vaccines Market Analysis and Forecast (2017-2027)
14.1 Introduction
14.2 Middle East & Africa Human Vaccines Market Analysis, By Technology
14.3 Middle East & Africa Human Vaccines Market Analysis, By Patient Type
14.4 Middle East & Africa Human Vaccines Market Analysis, By Infection Type
14.4 Middle East & Africa Human Vaccines Market Analysis, By Route of Administration
15. Competition Analysis
15.1 Competition Dashboard
15.2 Market Share Analysis of Top Vendors
15.3 Key Development Strategies
16. Company Profiles
16.1 GlaxoSmithKline PLC
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financial
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Pfizer Inc
16.3 Merck & Co. Inc.,
16.4 Sanofi Pasteur SA
16.5 Johnson& Johnson
16.6 AstraZeneca
16.7 Serum Institute of India Pvt. Ltd
16.8 Daiichi Sankyo Company Limited
15.9 Biofood Systems Limited
16.10 Bavarian Nordic
16.11 Biological
16.12 CSL Limited
16.13 Bharat Biotech

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us